tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brandon Folkes, 127 are a BUY (85.81%), 1 are a SELL (0.68%), 20 are a HOLD (13.51%).
Analyst Brandon Folkes, carries an average stock price target met ratio of 35.67% that have a potential upside of 30.42% achieved within 256 days. Previously, Brandon Folkes worked at HC WAINWRIGHT.
Brandon Folkes’s has documented 292 price targets and ratings displayed on 38 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRMD, CorMedix at 13-Nov-2025.
Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for OMER (OMEROS) at 11/14/2024. The price target of $9 was fulfilled within 8 days with a profit of $2.05 (29.5%) receiving and performance score of 36.87.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6
$0.41 (7.33%)
$8
3 years 10 months 15 days ago
(25-Feb-2022)
1/4 (25%)
$2.17 (44.83%)
281
Hold
Since 14-Feb-2022
$5
$-0.59 (-10.55%)
3 years 10 months 26 days ago
(14-Feb-2022)
0/1 (0%)
$-0.56 (-10.07%)
Hold
Since 05-Nov-2021
$4.5
$-1.09 (-19.50%)
3 years 11 months 19 days ago
(21-Jan-2022)
4/4 (100%)
$1.14 (33.93%)
167
Buy
Since 06-May-2021
$6.25
$0.66 (11.81%)
$5
4 years 8 months 3 days ago
(06-May-2021)
1/2 (50%)
$3.07 (96.54%)
287
Buy
$8
$2.41 (43.11%)
6 years 1 months 27 days ago
(13-Nov-2019)
1/2 (50%)
$2.26 (36.00%)
1683
Which stock is Brandon Folkes is most bullish on?
Which stock is Brandon Folkes is most reserved on?
What Year was the first public recommendation made by Brandon Folkes?
